Loading insider details...
Beta
Latest Form 4 (Jun 26, 2026): Grant/Award of 45,000 CNTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 26, 2026 | Context Therapeutics Inc. (CNTX) | Grant/Award | 45,000 | n/a |
| Jun 12, 2025 | Context Therapeutics Inc. (CNTX) | Grant/Award | 123,500 | n/a |
| Jun 14, 2024 | Context Therapeutics Inc. (CNTX) | Grant/Award | 25,000 | n/a |
| Jul 5, 2023 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 23,382 | n/a |
| Jun 16, 2023 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 48,000 | n/a |
| May 31, 2023 | Context Therapeutics Inc. (CNTX) | Grant/Award | 25,000 | n/a |
| Jul 5, 2022 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 58,496 | n/a |
| Jun 16, 2022 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 15,000 | n/a |
| Jun 3, 2022 | Context Therapeutics Inc. (CNTX) | Grant/Award | 25,000 | n/a |
| Dec 20, 2021 | Galera Therapeutics, Inc. (GRTX) | Purchase | 20,000 | $54.8K |